(Q37063632)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

review article

1 reference

title

Implications of cross-talk between tumour necrosis factor and insulin-like growth factor-1 signalling in skeletal muscle (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Marie A Bogoyevitch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Hannah G Radley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Bijanka L Gebski

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Thea Shavlakadze

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

21 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Experimental Pharmacology and Physiology

1 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

846-851

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18215180%20AND%20SRC:MED&resulttype=core&format=json

Strength at the extracellular matrix-muscle interface.

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Muscle damage in mdx (dystrophic) mice: role of calcium and reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

The allure of stem cell therapy for muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Prednisolone decreases cellular adhesion molecules required for inflammatory cell infiltration in dystrophin-deficient skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Weekly oral prednisolone improves survival and strength in malemdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Evolving therapeutic strategies for Duchenne muscular dystrophy: targeting downstream events

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Duchenne muscular dystrophy: focus on pharmaceutical and nutritional interventions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Nutritional therapy improves function and complements corticosteroid intervention in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Damage and inflammation in muscular dystrophy: potential implications and relationships with autoimmune myositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Inflammatory processes in muscle injury and repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Deferoxamine reduces and nitric oxide synthase inhibition increases neutrophil-mediated myotube injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

The role of neutrophils in injury and repair following muscle stretch

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Administration of the non-steroidal anti-inflammatory drug ibuprofen increases macrophage concentrations but reduces necrosis during modified muscle use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

A chronic inflammatory response dominates the skeletal muscle molecular signature in dystrophin-deficient mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

The adipose tissue as a source of vasoactive factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Tumor necrosis factor-alpha promotes the accumulation of neutrophils and macrophages in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Anti-TNFalpha (Remicade) therapy protects dystrophic skeletal muscle from necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Pathogenesis of malaria and clinically similar conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Interplay of IKK/NF-kappaB signaling in macrophages and myofibers promotes muscle degeneration in Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Mechanical stress activates the nuclear factor-kappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Modulation of p38 mitogen-activated protein kinase cascade and metalloproteinase activity in diaphragm muscle in response to free radical scavenger administration in dystrophin-deficient Mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Targeted expression of insulin-like growth factor-I reduces early myofiber necrosis in dystrophic mdx mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Reasons for the degeneration of ageing skeletal muscle: a central role for IGF-1 signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Of bears, frogs, meat, mice and men: complexity of factors affecting skeletal muscle mass and fat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Early regeneration of whole skeletal muscle grafts is unaffected by overexpression of IGF-1 in MLC/mIGF-1 transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Insulin-like growth factor isoforms in skeletal muscle aging, regeneration, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Reconciling data from transgenic mice that overexpress IGF-I specifically in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Muscle-specific expression of insulin-like growth factor I counters muscle decline in mdx mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Tumor Necrosis Factor-α Decreases Insulin-Like Growth Factor-I Messenger Ribonucleic Acid Expression in C2C12 Myoblasts via a Jun N-Terminal Kinase Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

IL-1beta impairs insulin-like growth factor i-induced differentiation and downstream activation signals of the insulin-like growth factor i receptor in myoblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Cytokine-hormone interactions: tumor necrosis factor alpha impairs biologic activity and downstream activation signals of the insulin-like growth factor I receptor in myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Proinflammatory cytokine impairment of insulin-like growth factor I-induced protein synthesis in skeletal muscle myoblasts requires ceramide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

C-jun N-terminal kinase mediates tumor necrosis factor-alpha suppression of differentiation in myoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Insulin/IGF-1 and TNF-alpha stimulate phosphorylation of IRS-1 at inhibitory Ser307 via distinct pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Therapeutic promise of JNK ATP-noncompetitive inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Insulin-like growth factor-1 downregulates nuclear factor kappa B activation and upregulates interleukin-8 gene expression induced by tumor necrosis factor alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Targeted ablation of IKK2 improves skeletal muscle strength, maintains mass, and promotes regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X

Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health ABC Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2007.04868.X